Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-07-19

Clinical Trial Update: Response of Children With Atopic Dermatitis (Eczema) to Eucrisa [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating response of children with atopic dermatitis (eczema) to Eucrisa.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Eucrisa (crisaborole)

Snippet

Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago | Conditions: Atopic Dermatitis, Eczema | Phase 4 | Status: COMPLETED